Evidence map›Paper›PMID 34815258›Full record

ArticleCMAJ open

Developing a patient-oriented realist evaluation for COVID-19 vaccine implementation in Saskatchewan: a methodologic framework.

Amir Reza Azizian, Tracey Carr, Nazeem Muhajarine, Tanya Verrall, Collin Hartness, Jason Vanstone, Maryam Yasinian, Candace Skrapek, Brenda Andreas, Gerald Farthing and 1 more

Abstract read
In one paragraph

Article in CMAJ open. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Amir Reza AzizianDepartment of Community Health and Epidemiology (Azizian, Carr, Muhajarine, Yasinian, Groot), College of Medicine, University of Saskatchewan; Saskatchewan Health Quality Council (Verrall), Saskatoon, Sask.; Saskatchewan Health Authority (Azizian, Groot, Hartness, Vanstone), Regina, Sask.; patient partner (Skrapek), Saskatoon, Sask.; patient partner (Andreas), Maple Creek, Sask.; family partner (Farthing), Saskatoon, Sask.
Tracey CarrDepartment of Community Health and Epidemiology (Azizian, Carr, Muhajarine, Yasinian, Groot), College of Medicine, University of Saskatchewan; Saskatchewan Health Quality Council (Verrall), Saskatoon, Sask.; Saskatchewan Health Authority (Azizian, Groot, Hartness, Vanstone), Regina, Sask.; patient partner (Skrapek), Saskatoon, Sask.; patient partner (Andreas), Maple Creek, Sask.; family partner (Farthing), Saskatoon, Sask.
Nazeem MuhajarineDepartment of Community Health and Epidemiology (Azizian, Carr, Muhajarine, Yasinian, Groot), College of Medicine, University of Saskatchewan; Saskatchewan Health Quality Council (Verrall), Saskatoon, Sask.; Saskatchewan Health Authority (Azizian, Groot, Hartness, Vanstone), Regina, Sask.; patient partner (Skrapek), Saskatoon, Sask.; patient partner (Andreas), Maple Creek, Sask.; family partner (Farthing), Saskatoon, Sask.
Tanya VerrallDepartment of Community Health and Epidemiology (Azizian, Carr, Muhajarine, Yasinian, Groot), College of Medicine, University of Saskatchewan; Saskatchewan Health Quality Council (Verrall), Saskatoon, Sask.; Saskatchewan Health Authority (Azizian, Groot, Hartness, Vanstone), Regina, Sask.; patient partner (Skrapek), Saskatoon, Sask.; patient partner (Andreas), Maple Creek, Sask.; family partner (Farthing), Saskatoon, Sask.
Collin HartnessDepartment of Community Health and Epidemiology (Azizian, Carr, Muhajarine, Yasinian, Groot), College of Medicine, University of Saskatchewan; Saskatchewan Health Quality Council (Verrall), Saskatoon, Sask.; Saskatchewan Health Authority (Azizian, Groot, Hartness, Vanstone), Regina, Sask.; patient partner (Skrapek), Saskatoon, Sask.; patient partner (Andreas), Maple Creek, Sask.; family partner (Farthing), Saskatoon, Sask.
Jason VanstoneDepartment of Community Health and Epidemiology (Azizian, Carr, Muhajarine, Yasinian, Groot), College of Medicine, University of Saskatchewan; Saskatchewan Health Quality Council (Verrall), Saskatoon, Sask.; Saskatchewan Health Authority (Azizian, Groot, Hartness, Vanstone), Regina, Sask.; patient partner (Skrapek), Saskatoon, Sask.; patient partner (Andreas), Maple Creek, Sask.; family partner (Farthing), Saskatoon, Sask.
Maryam YasinianDepartment of Community Health and Epidemiology (Azizian, Carr, Muhajarine, Yasinian, Groot), College of Medicine, University of Saskatchewan; Saskatchewan Health Quality Council (Verrall), Saskatoon, Sask.; Saskatchewan Health Authority (Azizian, Groot, Hartness, Vanstone), Regina, Sask.; patient partner (Skrapek), Saskatoon, Sask.; patient partner (Andreas), Maple Creek, Sask.; family partner (Farthing), Saskatoon, Sask.
Candace SkrapekDepartment of Community Health and Epidemiology (Azizian, Carr, Muhajarine, Yasinian, Groot), College of Medicine, University of Saskatchewan; Saskatchewan Health Quality Council (Verrall), Saskatoon, Sask.; Saskatchewan Health Authority (Azizian, Groot, Hartness, Vanstone), Regina, Sask.; patient partner (Skrapek), Saskatoon, Sask.; patient partner (Andreas), Maple Creek, Sask.; family partner (Farthing), Saskatoon, Sask.
Brenda AndreasDepartment of Community Health and Epidemiology (Azizian, Carr, Muhajarine, Yasinian, Groot), College of Medicine, University of Saskatchewan; Saskatchewan Health Quality Council (Verrall), Saskatoon, Sask.; Saskatchewan Health Authority (Azizian, Groot, Hartness, Vanstone), Regina, Sask.; patient partner (Skrapek), Saskatoon, Sask.; patient partner (Andreas), Maple Creek, Sask.; family partner (Farthing), Saskatoon, Sask.
Gerald FarthingDepartment of Community Health and Epidemiology (Azizian, Carr, Muhajarine, Yasinian, Groot), College of Medicine, University of Saskatchewan; Saskatchewan Health Quality Council (Verrall), Saskatoon, Sask.; Saskatchewan Health Authority (Azizian, Groot, Hartness, Vanstone), Regina, Sask.; patient partner (Skrapek), Saskatoon, Sask.; patient partner (Andreas), Maple Creek, Sask.; family partner (Farthing), Saskatoon, Sask.
Gary GrootDepartment of Community Health and Epidemiology (Azizian, Carr, Muhajarine, Yasinian, Groot), College of Medicine, University of Saskatchewan; Saskatchewan Health Quality Council (Verrall), Saskatoon, Sask.; Saskatchewan Health Authority (Azizian, Groot, Hartness, Vanstone), Regina, Sask.; patient partner (Skrapek), Saskatoon, Sask.; patient partner (Andreas), Maple Creek, Sask.; family partner (Farthing), Saskatoon, Sask. Gary.groot@usask.ca.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThere is an urgent need to inform decision-making and safe delivery of vaccines in a timely manner. Our objective is to describe the methods we used to perform a patient-oriented realist evaluation of COVID-19 vaccination implementation in Saskatchewan, Canada, in order to understand the underlying mechanisms and contexts of vaccination implementation and vaccine uptake.

methodsThis methodology paper describes a patient-oriented, realist, mixed-method evaluation to assess COVID-19 vaccination implementation in Regina, Saskatoon and Prince Albert, Saskatchewan. The study comprised 3 iterative phases guided by Realist And Meta-narrative Evidence Synthesis: Evolving Standards II (RAMESES II). In phase 1 (January-February 2021), we developed the initial program theory, in phase 2 (March-May 2021), we tested and refined the initial program theory, and in phase 3 (June-July 2021), we established the final program theory. Three patient and family partners with different backgrounds and experiences were selected purposively from various locations (urban and rural) in Saskatchewan to engage collaboratively in the evaluation. Data analysis and synthesis occurred at all 3 phases of the project. We analysed qualitative data from phases 2 and 3 using a "retroductive" approach. We used quantitative data to compare outcomes from the 3 sites.

interpretationThis protocol describes how we developed a final program theory for COVID-19 vaccination implementation with patient and family partners to show for whom, under what circumstances, how and why Saskatchewan's COVID-19 vaccination program has led to vaccine uptake. With patient and family partners' engagement, the evaluation findings will be shared with the Saskatchewan Health Authority and provincial government policy-makers and communications departments, published in peer-reviewed journals, presented at provincial or national conferences, and disseminated through any additional media identified by the patient and family partners.

Indexed as

COVID-19COVID-19 VaccinesDelivery of Health CareHumansProgram EvaluationResearch DesignSARS-CoV-2SaskatchewanVaccinationCOVID-19 Vaccines

Identifiers

PMID34815258
PMCPMC8612651

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.